The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

Sanofi and Regeneron Pharmaceuticals drug Dupixent has won FDA approval for chronic spontaneous urticaria, introducing a new approach to the treatment of this inflammatory skin disorder.

UnitedHealth Group took quite the tumble on Thursday and Medicare Advantage troubles seem to largely be at fault. Its shares fell by over 22% after its first quarter earnings on Thursday.

The scent of eucalyptus oil wafts through more households than ever. Herbal teas promising immunity boosts line mainstream grocery store shelves. Social media teems with influencers touting the ...

With rising operational costs, major shifts in Medicaid, and other financial pressures bearing down on the healthcare system, forecasting revenue and allocating resources effectively has never ...

The Department of Health and Human Services has long advocated vaccination as a key component of public health. Before Robert F. Kennedy, Jr. was confirmed as secretary of the nation’s top ...